Erik Harris - Net Worth and Insider Trading
Erik Harris Net Worth
The estimated net worth of Erik Harris is at least $3 Million dollars as of 2024-11-13. Erik Harris is the EVP & Chief Commercial Officer of Ultragenyx Pharmaceutical Inc and owns about 67,163 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $3 Million. Details can be seen in Erik Harris's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Erik Harris has not made any transactions after 2024-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Erik Harris
Erik Harris Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Erik Harris owns 2 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , and Denali Therapeutics Inc (DNLI) .
Click here to see the complete history of Erik Harris’s form 4 insider trades.
Insider Ownership Summary of Erik Harris
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2024-03-01 | EVP & Chief Commercial Officer |
| DNLI | Denali Therapeutics Inc | 2022-02-03 | director |
Erik Harris Latest Holdings Summary
Erik Harris currently owns a total of 1 stock. Erik Harris owns 67,163 shares of Ultragenyx Pharmaceutical Inc (RARE) as of March 1, 2024, with a value of $3 Million.
Latest Holdings of Erik Harris
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2024-03-01 | 67,163 | 47.79 | 3,209,720 |
Holding Weightings of Erik Harris
Erik Harris Form 4 Trading Tracker
According to the SEC Form 4 filings, Erik Harris has made a total of 14 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 4,768 shares on March 1, 2024, which brought Erik Harris around $256,328.
Insider Trading History of Erik Harris
- 1
Erik Harris Trading Performance
Erik Harris Ownership Network
Ownership Network List of Erik Harris
Ownership Network Relation of Erik Harris
Erik Harris Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Erik Harris is the EVP & Chief Commercial Officer of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include Chief Financial Officer Howard Horn , director & 10 percent owner & President & CEO Emil D Kakkis , and Controller and PAO Theodore Alan Huizenga .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Erik Harris made 3 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 11,073. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 147,853 shares made by Emil D Kakkis , a net sale of 4,391 shares made by Sanders Corazon (corsee) D. , and a net sale of 3,565 shares made by Theodore Alan Huizenga .
In summary, during the past 3 months, insiders sold 27,556 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 27,556 shares. During the past 18 months, 260,421 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 260,421 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Erik Harris Mailing Address
Above is the net worth, insider trading, and ownership report for Erik Harris. You might contact Erik Harris via mailing address: 60 Leveroni Court, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
